中國新城市(01321.HK)完成董事培訓
格隆匯4月13日丨中國新城市(01321.HK)公吿,根據聯交所上市委員會於新聞稿中的指示2,施南路、施中安及金妮(前董事,現為另一家上市發行人董事)各自應於新聞稿發佈後90天內參加21小時的監管及法律主題及上市規則合規培訓,包括各至少三小時的(i)董事職責,(ii)企業管治守則,(iii)上市規則第14章規定,及(iv)上市規則第14A章的上市規則要求。
公司確認,(a)於指定期間內,各相關董事已完成由聯交所上市科批准的課程提供者("培訓提供者")提供的培訓;及(b)公司已於培訓完成後向聯交所上市科提供培訓提供者的全面遵守書面證明。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.